Mangoceuticals, Inc. (MGRX)
USD 2.45
(-5.04%)
USD 2.45
(-5.04%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -6.99 Million | -1.34 Million | -17.52 Thousand |
| Net Income | -9.21 Million | -1.99 Million | -17.7 Thousand |
| Depreciation & Amortization | 24.88 Thousand | 3863.00 | - |
| Deferred income taxes | -585.65 Thousand | -151.82 Thousand | - |
| Stock-based compensation | 624.46 Thousand | 234.08 Thousand | - |
| Change in working capital | 41.51 Thousand | 18.86 Thousand | - |
| Other non-cash items | 2.1 Million | 546.53 Thousand | 181.00 |
| Investing Cash Flow | -3519.00 | -43.1 Thousand | - |
| Investments in PPE | -3519.00 | -43.1 Thousand | - |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -3519.00 | - | - |
| Financing Cash Flow | 7.05 Million | 2.04 Million | 40.07 Thousand |
| Debt repayment | -167.46 Thousand | -25.07 Thousand | -39.27 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 7.22 Million | 2 Million | 800.00 |
| Other Financing Activities | 7.05 Million | 75 Thousand | 160.28 Thousand |
| Accounts receivables | 54.97 Thousand | - | - |
| Accounts payables | 107.09 Thousand | 33.67 Thousand | - |
| Inventory | -18.5 Thousand | - | - |
| Other working capital | -47.07 Thousand | -14.8 Thousand | - |
| Cash at beginning of period | 682.86 Thousand | 22.55 Thousand | - |
| Cash at end of period | 739 Thousand | 682.86 Thousand | 22.55 Thousand |
| Capital Expenditure | -3519.00 | -43.1 Thousand | - |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 56.14 Thousand | 660.31 Thousand | 22.55 Thousand |
| Free Cash Flow | -7 Million | -1.38 Million | -17.52 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.39 Million | -2.36 Million | -9.21 Million | -2.56 Million | -1.79 Million | -2.28 Million |
| Depreciation & Amortization | 3205.00 | 6224.00 | 24.88 Thousand | 6291.00 | 6292.00 | 6224.00 |
| Deferred income taxes | - | - | -585.65 Thousand | -386.87 Thousand | - | -764.2 Thousand |
| Stock-based compensation | 50.98 Thousand | 37.96 Thousand | 624.46 Thousand | 429.07 Thousand | 66.84 Thousand | 64.27 Thousand |
| Change in working capital | -289.56 Thousand | 915.79 Thousand | 41.51 Thousand | 76.03 Thousand | -69.17 Thousand | 55.74 Thousand |
| Other non-cash items | 1.43 Million | -447.35 Thousand | 2.1 Million | 745.77 Thousand | 84.75 Thousand | 443.03 Thousand |
| Investing Cash Flow | 65 Thousand | - | -3519.00 | 3519.00 | - | - |
| Investments in PPE | -4.00 | - | -3519.00 | 3519.00 | - | - |
| Acquisitions | 65 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 65 Thousand | - | -3519.00 | - | - | - |
| Financing Cash Flow | 1.98 Million | 267.5 Thousand | 7.05 Million | 1.2 Million | - | 935.3 Thousand |
| Debt repayment | -100 Thousand | -87.5 Thousand | -167.46 Thousand | -167.46 Thousand | - | -89.2 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.88 Million | 180 Thousand | 7.22 Million | 1.2 Million | - | 1.02 Million |
| Other Financing Activities | 1.98 Million | -149 Thousand | 7.05 Million | 1.2 Million | - | 935.3 Thousand |
| Accounts receivables | - | - | - | -23.49 Thousand | - | 23.49 Thousand |
| Accounts payables | -332.29 Thousand | 910.18 Thousand | 107.09 Thousand | 51.7 Thousand | -41.14 Thousand | 99.4 Thousand |
| Inventory | 433.00 | 4049.00 | -18.5 Thousand | 3080.00 | 1913.00 | -23.49 Thousand |
| Other working capital | 42.29 Thousand | 1568.00 | -47.07 Thousand | 21.24 Thousand | -29.93 Thousand | -43.66 Thousand |
| Cash at beginning of period | 15.3 Thousand | 739 Thousand | 682.86 Thousand | 1.23 Million | 2.94 Million | 3.79 Million |
| Cash at end of period | 490.24 Thousand | 15.3 Thousand | 739 Thousand | 739 Thousand | 1.23 Million | 2.94 Million |
| Capital Expenditure | -4.00 | - | -3519.00 | 3519.00 | - | - |
| Effect of forex changes on cash | -1096.00 | -70.00 | - | - | - | - |
| Net cash flow / Change in cash | 474.93 Thousand | -723.7 Thousand | 56.14 Thousand | -497.74 Thousand | -1.71 Million | -843.72 Thousand |
| Free Cash Flow | -1.57 Million | -991.13 Thousand | -7 Million | -1.69 Million | -1.71 Million | -1.77 Million |
GOCLCORP
MCAS
2745
SIKA
KNTPF
POLA